Research graph
References from Neuroprotective effects of oleuropein on dopamine level and caspase-3 activity in zebrafish model of Parkinson’s disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Oleuropein prevents neuronal death, mitigates mitochondrial superoxide production and modulates autophagy in a dopaminergic cellular model
10.3390/ijms17081293 · 2016 · External reference
Bioactivity of olive oil phenols in neuroprotection
10.3390/ijms18112230 · 2017 · External reference
Oleuropein aglycone, an olive polyphenol, influences alpha-synuclein aggregation and exerts neuroprotective effects in different Parkinson’s disease models
10.1007/s12035-025-05208-6 · 2025 · External reference
Chronic systemic pesticide exposure reproduces features of Parkinson’s disease
10.1038/81834 · 2000 · External reference
Neuroprotective effects of oleuropein: Recent developments and contemporary research
10.1111/jfbc.13967 · 2021 · External reference
Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies
10.1111/j.1476-5381.2012.02025.x · 2012 · External reference
The Parkinson pandemic-a call to action
10.1001/jamaneurol.2017.3299 · 2018 · External reference
Animal models of Parkinson’s disease: A source of novel treatments and clues to the cause of the disease
10.1111/j.1476-5381.2011.01426.x · 2011 · External reference
Apoptosis and its therapeutic implications in neurodegenerative diseases
10.1002/ca.23792 · 2022 · External reference
Common myths in the use of levodopa in Parkinson disease: When clinical trials misinform clinical practice
10.1001/jamaneurol.2017.0348 · 2017 · External reference
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease
10.1073/pnas.040556597 · 2000 · External reference
Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation
10.1038/srep45465 · 2017 · External reference
Parkinson’s disease: Etiology, neuropathology, and pathogenesis
10.15586/codonpublications.parkinsonsdisease.2018.ch1 · 2018 · External reference
Therapeutic targeting of mitophagy in Parkinson’s disease
10.1042/bst20211107 · 2022 · External reference
Phenolic compounds and antioxidant activity of Olea europaea L. Fruits and leaves
10.1177/1082013206070166 · 2006 · External reference
Oleuropein confers neuroprotection against rotenone-induced model of Parkinson’s disease via BDNF/CREB/Akt pathway
10.1038/s41598-023-29287-4 · 2023 · External reference
Multi-step usage of in vivo models during rational drug design and discovery
10.3390/ijms12042262 · 2011 · External reference
Common myths in the use of levodopa in Parkinson disease: When clinical trials misinform clinical practice
10.1001/jamaneurol.2017.0348 · ExternalCitation · doi-reference
The Parkinson pandemic-a call to action
10.1001/jamaneurol.2017.3299 · ExternalCitation · doi-reference
Apoptosis and its therapeutic implications in neurodegenerative diseases
10.1002/ca.23792 · ExternalCitation · doi-reference
Oleuropein aglycone, an olive polyphenol, influences alpha-synuclein aggregation and exerts neuroprotective effects in different Parkinson’s disease models
10.1007/s12035-025-05208-6 · ExternalCitation · doi-reference
Chronic systemic pesticide exposure reproduces features of Parkinson’s disease
10.1038/81834 · ExternalCitation · doi-reference
Oleuropein confers neuroprotection against rotenone-induced model of Parkinson’s disease via BDNF/CREB/Akt pathway
10.1038/s41598-023-29287-4 · ExternalCitation · doi-reference
Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation
10.1038/srep45465 · ExternalCitation · doi-reference
Therapeutic targeting of mitophagy in Parkinson’s disease
10.1042/bst20211107 · ExternalCitation · doi-reference
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease
10.1073/pnas.040556597 · ExternalCitation · doi-reference
Animal models of Parkinson’s disease: A source of novel treatments and clues to the cause of the disease
10.1111/j.1476-5381.2011.01426.x · ExternalCitation · doi-reference
Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies
10.1111/j.1476-5381.2012.02025.x · ExternalCitation · doi-reference
Neuroprotective effects of oleuropein: Recent developments and contemporary research
10.1111/jfbc.13967 · ExternalCitation · doi-reference
Phenolic compounds and antioxidant activity of Olea europaea L. Fruits and leaves
10.1177/1082013206070166 · ExternalCitation · doi-reference
Parkinson’s disease: Etiology, neuropathology, and pathogenesis
10.15586/codonpublications.parkinsonsdisease.2018.ch1 · ExternalCitation · doi-reference
Multi-step usage of in vivo models during rational drug design and discovery
10.3390/ijms12042262 · ExternalCitation · doi-reference
Oleuropein prevents neuronal death, mitigates mitochondrial superoxide production and modulates autophagy in a dopaminergic cellular model
10.3390/ijms17081293 · ExternalCitation · doi-reference
Bioactivity of olive oil phenols in neuroprotection
10.3390/ijms18112230 · ExternalCitation · doi-reference
